Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis

OBJECTIVES: To characterize individual participant level response distributions to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration from 1979 to 2016. DESIGN: Individual participant data analysis. POPULATION: 23...

Descripción completa

Detalles Bibliográficos
Autores principales: Stone, Marc B, Yaseen, Zimri S, Miller, Brian J, Richardville, Kyle, Kalaria, Shamir N, Kirsch, Irving
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344377/
https://www.ncbi.nlm.nih.gov/pubmed/35918097
http://dx.doi.org/10.1136/bmj-2021-067606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344377/
https://www.ncbi.nlm.nih.gov/pubmed/35918097
http://dx.doi.org/10.1136/bmj-2021-067606

Ejemplares similares